Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zithromax Product Donations Enhance Brand Image, Pfizer Tells Analysts

Executive Summary

Pfizer's research and product donation programs for Zithromax in the developing world help to build the brand's image with infectious disease specialists, Global Pharmaceuticals President Karen Katen told analysts during Pfizer's recent business review.

You may also be interested in...



Exports For Foreign Trials Would Need Ethics Review Under Rep. Lantos Bill

A bill by Rep. Tom Lantos (D-Ca.) would require drug manufacturers exporting test product for overseas clinical trials to prove that the foreign protocol would pass U.S. standards for human subject protection

Exports For Foreign Trials Would Need Ethics Review Under Rep. Lantos Bill

A bill by Rep. Tom Lantos (D-Ca.) would require drug manufacturers exporting test product for overseas clinical trials to prove that the foreign protocol would pass U.S. standards for human subject protection

Glaxo Malarone Malaria Prophylaxis Will Subsidize Africa Donation Program

Glaxo is launching the anti-malarial agent Malarone at a price $1 per tablet higher in the U.S. than in the U.K.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037125

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel